Skip to content

It looks like we may have content for your preferred language. Would you like to view this page in English?

Alternative Approach to Accessing the U.S. Public Market

Represented a Nasdaq pharmaceutical company in its alternative approach to accessing the U.S. public market, its underwritten public offering and its at-the-market offering.